|Articles|March 19, 2020
Oncology Product Manufacturing in a Nondedicated Facility
Author(s)Baxter BioPharma Solutions
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
Optimizing Pharmaceutical Manufacturing Efficiency
3
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
4
Regulatory Expectations for Evaluating GMP Facilities and Equipment
5
